Share This Page
Drug Price Trends for DEXLANSOPRAZOLE DR
✉ Email this page to a colleague
Average Pharmacy Cost for DEXLANSOPRAZOLE DR
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DEXLANSOPRAZOLE DR 30 MG CAP | 24979-0703-06 | 4.38666 | EACH | 2025-05-21 |
| DEXLANSOPRAZOLE DR 30 MG CAP | 24979-0001-06 | 4.38666 | EACH | 2025-05-21 |
| DEXLANSOPRAZOLE DR 60 MG CAP | 49884-0148-11 | 4.62377 | EACH | 2025-05-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Dexlansoprazole Market Analysis and Price Projections
Market Size and Growth Projections
The dexlansoprazole market is experiencing significant growth driven by several key factors. As of 2023, the global dexlansoprazole market size was valued at USD 100 million and is projected to reach USD 147 million by 2031, growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031[2].
Regional Market Analysis
North America
North America holds a major share of the global dexlansoprazole market, accounting for more than 40% of the global revenue. The market size in North America was estimated at USD XX million in 2024 and is expected to grow at a CAGR of 4.2% from 2024 to 2031. The growth is driven by increasing awareness of gastroesophageal reflux disease (GERD), an aging population, and advancements in healthcare infrastructure[1][3].
Europe
Europe accounts for over 30% of the global market size, with a market value of USD XX million in 2024. The European market is expected to expand at a CAGR of 4.5% from 2024 to 2031. The rising prevalence of GERD and an aging population are key drivers of this growth[1].
Asia Pacific
The Asia Pacific region holds around 23% of the global revenue, with a market size of USD XX million in 2024. This region is expected to grow at a CAGR of 8.0% from 2024 to 2031, driven by increasing GERD awareness, a growing senior population, and improvements in healthcare infrastructure[1].
Latin America and Middle East & Africa
In Latin America, the market is expected to grow at a CAGR of 5.4% from 2024 to 2031, driven by rising GERD prevalence and increased awareness of treatment options. The Middle East and Africa region, though smaller, is also growing at a CAGR of 5.7% during the same period, driven by similar factors[1].
Market Segmentation
The dexlansoprazole market is segmented based on type and application.
By Type
The market includes various formulations such as capsules, tablets, delayed-release capsules, oral suspension, and dispersible tablets. Delayed-release capsules, in particular, are popular due to their extended-release characteristics, providing long-lasting symptom relief[2].
By Application
Dexlansoprazole is used to treat conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, heartburn, Zollinger-Ellison syndrome, and gastric ulcers. The increasing prevalence of these conditions globally is a significant driver of market growth[2].
Key Drivers and Trends
- Increasing Prevalence of GERD and Peptic Ulcers: The global rise in cases of GERD and peptic ulcers is a major factor driving the demand for dexlansoprazole[2].
- Aging Population: The elderly population is more prone to digestive disorders, making them a significant demographic driving market expansion[2].
- Advancements in Pharmaceutical Technology: Improvements in drug formulations and delivery systems, such as extended-release capsules, are enhancing patient compliance and efficacy[2].
- Rising Healthcare Costs and Improved Access to Modern Medical Care: In developing nations, the increasing access to modern medical care and rising healthcare costs are contributing to market growth[2].
Price Projections and Affordability
The cost of dexlansoprazole varies based on the dosage and formulation. For example, a supply of 30 capsules of 60 mg oral delayed-release capsules can cost around $277, depending on the pharmacy[5].
Price Range
- 30 mg Oral Delayed Release Capsule: $276.88 - $313.66 for 30 capsules
- 60 mg Oral Delayed Release Capsule: $276.88 - $315.32 for 30 capsules[5]
Competitive Landscape
The market is dominated by several key players, including:
- Takeda Pharmaceutical
- Teva Pharmaceuticals
- Mylan
- Sun Pharmaceutical
- Sandoz
- Dr. Reddy's Laboratories
- Cipla
- Lupin Pharmaceuticals
- Aurobindo Pharma
- Zydus Cadila
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals[2].
Sustained Release Capsule Market
The global market for dexlansoprazole sustained release capsules was estimated to be worth US$ 298 million in 2023 and is forecast to reach US$ 428.1 million by 2030, growing at a CAGR of 5.3% during the forecast period 2024-2030. Key players in this segment include TAKEDA PHARM, PAR PHARM, and TWI PHARM[4].
Key Takeaways
- The global dexlansoprazole market is projected to grow significantly due to increasing GERD prevalence and an aging population.
- North America, Europe, and Asia Pacific are the leading regions in terms of market share.
- Extended-release formulations are driving market growth due to their efficacy in providing long-lasting symptom relief.
- Advancements in pharmaceutical technology and rising healthcare costs are also key drivers.
- The market is competitive with several major pharmaceutical companies involved.
Frequently Asked Questions (FAQs)
Q: What is the projected global market size for dexlansoprazole by 2031? A: The global dexlansoprazole market is expected to reach USD 147 million by 2031[2].
Q: Which region holds the largest share of the global dexlansoprazole market? A: North America holds more than 40% of the global revenue[1].
Q: What are the main drivers of the dexlansoprazole market growth? A: The main drivers include the increasing prevalence of GERD, an aging population, and advancements in pharmaceutical technology[2].
Q: What are the different formulations of dexlansoprazole available in the market? A: The market includes capsules, tablets, delayed-release capsules, oral suspension, and dispersible tablets[2].
Q: How much does a supply of 30 capsules of 60 mg dexlansoprazole typically cost? A: The cost can range from $276.88 to $315.32, depending on the pharmacy[5].
Cited Sources:
- Cognitive Market Research - Dexlansoprazole market size will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.
- Market Research Intellect - Dexlansoprazole Market Size and Projections.
- Cognitive Market Research - North America Dexlansoprazole Industry Report 2024.
- Valuates Reports - Dexlansoprazole Sustained Release Capsule - Market Size.
- Drugs.com - Dexlansoprazole Prices, Coupons, Copay Cards & Patient Assistance.
More… ↓
